Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study

Abstract Introduction Fractional exhaled nitric oxide (FeNO) is an important type 2 (T2) asthma biomarker. Home-based FeNO monitoring can provide longitudinal data better reflecting the variable nature of T2 inflammation versus single-point data. We sought to compare longitudinal mean FeNO and varia...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kai M. Beeh, Tim Harrison, Enrico Heffler, Hartmut Timmermann, Stephan Weber, Sandra Wegner
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2025-12-01
coleção:	Pulmonary Therapy
Assuntos:	Asthma Exhaled nitric oxide Diagnosis Inflammation monitoring Biomarker Asthma control
Acesso em linha:	https://doi.org/10.1007/s41030-025-00336-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!